Dr. Rutledge et al., POLYMORPHISM OF THE ANGIOTENSIN-I CONVERTING-ENZYME GENE IN ESSENTIALHYPERTENSIVE PATIENTS, Biochemistry and molecular biology international, 35(3), 1995, pp. 661-668
Insertion/deletion (I/D) polymorphism of the angiotensin I converting
enzyme (ACE) gene has been associated with ischemic heart disease and
hypertension. The D allele reportedly correlates with myocardial infar
ction and it has been suggested that it may serve as the basis of popu
lation-based risk assessment. Similarly, determining whether there is
an ACE allele pattern associated with hypertension could be useful in
developing screening strategies. Previous reports have not shown consi
stent findings in Caucasian and Japanese population groups, some havin
g a predominance of the I allele. Although African Americans have the
highest prevalence of hypertension in the world, their ACE gene polymo
rphism frequencies have not been clearly defined. We studied the allel
e and genotype frequencies in this group, consisting of 133 essential
hypertensive subjects, and compared their findings with those reported
from normotensive African Americans and from other racial groups. The
black patients had a different allele distribution than the other pop
ulations in that the D was more common than the I allele, occurring at
a rate of 59.7%. The most common genotype was DD and it was present i
n 42.5% of the hypertensive subjects in contrast to the ID genotype wh
ich was the most commonly reported genotype in normotensive individual
s, The genotype pattern (frequencies of II, ID, DD) was significantly
different (p<0.005, 2 df) from Japanese and Caucasian (Scotland and Au
stralia) populations. There was no common allele or genotype distribut
ion amongst these diverse hypertensive groups. In summary, African Ame
ricans with essential hypertension most commonly have the D allele ACE
gene polymorphism and the DD genotype; however, investigators need to
be aware that there are major population differences in the allele an
d genotype frequencies and this could make the polymorphisms a problem
atic screening tool for hypertension.